Академический Документы
Профессиональный Документы
Культура Документы
Summary
Unconjugated Br: conjugation failure
Conjugated Br: excretion failure postconjugation
Urinary urobilinogen: Br passing into bowel
Pre-hepatic jaundice
Unconjugated hyperbilirubinaemia
Other LFTs usually normal
Increased production
Haemolysis
Br production exceeds conjugation capacity
Excess Br reuxes into blood
No hepatocyte damage No obstruction to Reduced conjugation drainage Drugs e.g. ABx Gilbert syndrome
Gilbert syndrome
Reduced expression of UGT1A1
Mutation in promotor sequence
Enough action normally
Stress normally reduces UGT1A1 expression
Jaundice with sepsis
Intrahepatic jaundice
Conjugated hyperbilirubinaemia
Usually
Unconjugated if severe hepatocyte loss
Conjugated Br in blood
Water soluble
Into urine
Dark urine
Drugs
Post-hepatic jaundice
Back pressure
Reux into blood
Conjugated hyperbilirubinaemia
Dark urine
Raised Br
Massively raised ALP & GGT
Mildly raised ALT & AST
Bile toxic to hepatocytes
Collateral damage
Outside wall:
Cancer of pancreatic head
Lymphadenopathy
In wall:
PSC
Cholangiocarcinoma
Stricture
Stones in gallbladder
Contraction of GB on stone
Biliary colic
(Or if in GB)
Worse with fatty meals
In GB or cystic duct
Biliary colic
Generally well
Intermittent RUQ pain
Biliary colic
Essentially normal exam
No peritonitis
USS: stones in gallbladder
Not seen on XR
Acute cholecystitis
Generally UNwell
Acute cholecystitis
Ill patient
Murphys sign positive
Mildly raised LFTs
Stone in GB neck
GB oedema
Cholangitis
Quickly deteriorated
Cholangitis
Raised LFTs
Courvoisier's law
Palpable gallbladder in presence of jaundice is usually not due to gallstones Stones - chronic cholecytitis - cannot dilate Tumour: pancreatic or bile duct (cholangiocarcinoma)
Cirrhosis
Pathological term
Architectural disruption
Fibrosis
Regenerative nodules
Chronic damage
Inammation
(Not acute)
Causes of cirrhosis
Metabolic
Alcoholic liver disease
NAFLD
Other
Biliary:
PBC
PSC
Drugs
Cirrhosis
Decompensation
Portal hypertension
Hepatic failure
Portal hypertension
Porto-systemic anastamoses: Oesophgeal varices Splenomegaly & hypersplenism Thrombocytopenia Haemorrhoids Caput medusae Portal gastropathy Ascites Paracentesis Spironolactone Risk of spontaneous bacterial peritonitis Portal vein thrombosis Hepato-renal syndrome
Varices
Beta-blockers
Monitoring OGD
Banding / sclerotherapy
Causes of ascites
Malignant Hydrostatic pressure: cardiac, hepatic Hypoalbuminaemia Inflammatory (infective) Iatrogenic
Compensated cirrhosis
Sufficient function to meet demands No features of failure May have portal hypertension Stimulus for decompensation E.g. bleed, infection, alcohol
Hepatic failure
Encephalopathy Coagulopathy Hypoglycaemia Jaundice Worsening ascites Infection Hypoalbuminaemia
Hepatitis viruses
A & E
Acute only
Faeco-oral transmission
C
Chronic only
Blood transmission
Iatrogenic
IVDU
B
Acute or chronic
Acute blood/sex
Chronic perinatally
High risk chronicity
Low risk acute illness
D
Acute or chronic
Only in presence of B
Both to cirrhosis
Hepatitis B serology
HBsAg = current infection Anti-HBs Ab = previous infection or immunised HBeAg = current infection and replicating Anti-HBeAg = response to infection
Metabolic disease
Wilsons disease Copper accumulation
ATP27B mutation
Cannot excrete from hepatocytes
Cirrhosis
Neurological damage
Haemolysis
Renal failure Alpha-1-antitrypsin deciency Inactivates neutrophil enzymes
Accumulation of incorrectly folded enzyme in liver
Inammation cirrhosis
Haemochromatosis
Mutation in HFE gene
Excessive iron absorption
Liver cirrhosis
Diabetes & other endocrinopathy
Cardiomyopathy
Oestoarthritis
Paracetamol OD
150mg/Kg (or 12g) for severe damage Or a significant amount over a longer period Initially: asymptomatic 12-24hr: N&V 24-48hr: asymptomatic 48-72hr: RUQ pain, ALF renal failure